Other lipid agents × cardiovascular events

TrialThe New England journal of medicine2019

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.

Deepak L Bhatt et al.PubMed ↗Publisher ↗

What the trial testedrandomised · 8,179 people · 2019

Randomised comparison

Reduced cardiovascular events

−20%−34% to −2%

17 in 100 instead of 22

Bigger than 4 in 10 for cardiovascular events

As reported

HR 0.80, 95% CI 0.66–0.98

One number in the abstract

the abstract, start to end

death (4.3% vs. 5.2%; hazard ratio, 0.80; 95% CI, 0.66 to 0.98; P=0.03).

← favours treatmentfavours comparator →
could be chance
Cardiovascular events
HR 0.800.66–0.98
Other lipid agentsCardiovascular events

Other lipid agents × cardiovascular eventshelps?settled

unlikelylikely
0.800.50 without it
← favours treatmentfavours comparator →
more certainless certain
1 / 5

1,295 papers cite itlatest 60 shown

2019
2025
2026
this paperpooled ittrialcites it

7 trials

Full record →Abstract, authors, funding and every citing paper · PMID 30415628